The traditional Chinese medicines treat chronic heart failure and their main bioactive constituents and mechanisms
作者机构:Key Laboratory of Chinese Internal Medicine of Ministry of Education and BeijingDongzhimen HospitalBeijing University of Chinese MedicineBeijing 100700China
出 版 物:《Acta Pharmaceutica Sinica B》 (药学学报(英文版))
年 卷 期:2023年第13卷第5期
页 面:1919-1955页
核心收录:
学科分类:100506[医学-中医内科学] 1006[医学-中西医结合] 1005[医学-中医学] 100602[医学-中西医结合临床] 10[医学]
基 金:the National Key Research&Development Program of China(Grant Nos.2017YFC1700400,2017YFC1700403) National Natural Science Foundation of China(NNSFC Grant Nos.82073978,81725024,and 82104441) Beijing Natural Science Foundation(Grant No.JQ18026,China)
主 题:Natural ingredients Chronic heart failure Cardiac remodeling Chinese medicinal herbs Traditional Chinese medicine formula Multiple targets Constituent compatibility Synergistic effects
摘 要:Chronic heart failure(CHF)is a severe public health problem with increasing morbidity and mortality,any treatment targeting a single session is insufficient to tackle *** is characterized by reduced cardiac output resulting from neurohumoral dysregulation and cardiac remodeling,which might be related to oxidative stress,inflammation,endoplasmic reticulum stress,apoptosis,autophagy,mitochondrial function,and *** molecular mechanisms interact with each other through ***,Chinese medicinal herbs have been widely applied in the treatment of CHF,and therapeutic effects of Chinese medicinal herbs and their ingredients have been scientifically confirmed over the past *** Chinese medicine(TCM)with multiple components can confront the different pathogenesis of CHF through multiple *** review analyzes commonly used TCM patent drugs and TCM decoctions that are applicable to different stages of CHF based on clinical *** bioactive ingredients in Chinese medicinal herbs have been found to treat CHF via multiple molecular *** review comprehensively covers the key works on the effects and underlying mechanisms of TCM,herbal ingredients and synergistic effects of constituent compatibility in treating CHF,providing additional ideas to address this threat.